{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:39:33Z","timestamp":1721687973223},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T00:00:00Z","timestamp":1271030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T00:00:00Z","timestamp":1271030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1038\/bmt.2010.64","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T10:54:51Z","timestamp":1271069691000},"page":"90-97","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT"],"prefix":"10.1038","volume":"46","author":[{"given":"R","family":"Yanagisawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Katsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Shigemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Shiohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,12]]},"reference":[{"key":"BFbmt201064_CR1","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2165\/00003495-199346040-00009","volume":"46","author":"DH Peters","year":"1993","unstructured":"Peters DH, Fitton A, Plosker GL, Faulds D . Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 1993; 46: 746\u2013794.","journal-title":"Drugs"},{"key":"BFbmt201064_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0008-8749(91)90103-I","volume":"133","author":"CS Lin","year":"1991","unstructured":"Lin CS, Boltz RC, Siekierka JJ, Sigal NH . FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. Cell Immunol 1991; 133: 269\u2013284.","journal-title":"Cell Immunol"},{"key":"BFbmt201064_CR3","first-page":"2303","volume":"92","author":"V Ratanatharathorn","year":"1998","unstructured":"Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 1998; 92: 2303\u20132314.","journal-title":"Blood"},{"key":"BFbmt201064_CR4","first-page":"2062","volume":"96","author":"RA Nash","year":"2000","unstructured":"Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 2000; 96: 2062\u20132068.","journal-title":"Blood"},{"key":"BFbmt201064_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","volume":"28","author":"A Hiraoka","year":"2001","unstructured":"Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, Kodera Y et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28: 181\u2013185.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201064_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1083-8791(98)50005-5","volume":"4","author":"JR Wingard","year":"1998","unstructured":"Wingard JR, Nash RA, Przepiorka D, Klein JL, Weisdorf DJ, Fay JW et al. Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation. Biol Blood Marrow Transplant 1998; 4: 157\u2013163.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201064_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.bmt.1702032","volume":"24","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Devine S, Fay J, Uberti J, Wingard J . Practical considerations in the use of tacrolimus for allogeneic marrow transplantation. Bone Marrow Transplant 1999; 24: 1053\u20131056.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201064_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.bmt.1702472","volume":"26","author":"G Yanik","year":"2000","unstructured":"Yanik G, Levine JE, Ratanatharathorn V, Dunn R, Ferrara J, Hutchinson RJ . Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant 2000; 26: 161\u2013167.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201064_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/sj.bmt.1702588","volume":"26","author":"D Przepiorka","year":"2000","unstructured":"Przepiorka D, Blamble D, Hilsenbeck S, Danielson M, Krance R, Chan KW . Tacrolimus clearance is age-dependent within the pediatric population. Bone Marrow Transplant 2000; 26: 601\u2013605.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201064_CR10","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/sj.bmt.1702053","volume":"24","author":"P Mehta","year":"1999","unstructured":"Mehta P, Beltz S, Kedar A, Graham-Pole J, Wingard JR . Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation. Bone Marrow Transplant 1999; 24: 1323\u20131327.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201064_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00007890-200208270-00024","volume":"74","author":"A Yamauchi","year":"2002","unstructured":"Yamauchi A, Ieiri I, Kataoka Y, Tanabe M, Nishizaki T, Oishi R et al. Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. Transplantation 2002; 74: 571\u2013572.","journal-title":"Transplantation"},{"key":"BFbmt201064_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1034\/j.1600-6143.2003.00077.x","volume":"3","author":"H Zheng","year":"2003","unstructured":"Zheng H, Webber S, Zeevi A, Schuetz E, Zhang J, Bowman P et al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant 2003; 3: 477\u2013483.","journal-title":"Am J Transplant"},{"key":"BFbmt201064_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pharmthera.2006.04.006","volume":"112","author":"S Masuda","year":"2006","unstructured":"Masuda S, Inui K . An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112: 184\u2013198.","journal-title":"Pharmacol Ther"},{"key":"BFbmt201064_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/FPC.0b013e3282f9ac01","volume":"18","author":"M Fukudo","year":"2008","unstructured":"Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K et al. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenet Genomics 2008; 18: 413\u2013423.","journal-title":"Pharmacogenet Genomics"},{"key":"BFbmt201064_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1537-2995.2007.01109.x","volume":"47","author":"Y Nakazawa","year":"2007","unstructured":"Nakazawa Y, Saito S, Hasegawa Y, Yanagisawa R, Sakashita K, Kamijo T et al. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia. Transfusion 2007; 47: 326\u2013334.","journal-title":"Transfusion"},{"key":"BFbmt201064_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt201064_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1399-3046.2008.01065.x","volume":"13","author":"R Yanagisawa","year":"2009","unstructured":"Yanagisawa R, Nakazawa Y, Sakashita K, Tanaka M, Shikama N, Kamijo T et al. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies. Pediatr Transplant 2009; 13: 737\u2013745.","journal-title":"Pediatr Transplant"},{"key":"BFbmt201064_CR18","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/clinchem\/44.9.1942","volume":"44","author":"JL Cogill","year":"1998","unstructured":"Cogill JL, Taylor PJ, Westley IS, Morris RG, Lynch SV, Johnson AG . Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 1998; 44: 1942\u20131946.","journal-title":"Clin Chem"},{"key":"BFbmt201064_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/art.23261","volume":"58","author":"T Yamazaki","year":"2008","unstructured":"Yamazaki T, Masumoto J, Agematsu K, Sawai N, Kobayashi S, Shigemura T et al. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum 2008; 58: 864\u2013868.","journal-title":"Arthritis Rheum"},{"key":"BFbmt201064_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/FTD.0b013e3181838063","volume":"30","author":"M Miura","year":"2008","unstructured":"Miura M, Kagaya H, Satoh S, Inoue K, Saito M, Habuchi T et al. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Ther Drug Monit 2008; 30: 559\u2013564.","journal-title":"Ther Drug Monit"},{"key":"BFbmt201064_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.bmt.1701054","volume":"21","author":"GW Boswell","year":"1998","unstructured":"Boswell GW, Bekersky I, Fay J, Wingard J, Antin J, Weisdorf D et al. Tacrolimus pharmacokinetics in BMT patients. Bone Marrow Transplant 1998; 21: 23\u201328.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201064_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/sj.bmt.1700839","volume":"20","author":"JR Wingard","year":"1997","unstructured":"Wingard JR, Nash RA, Ratanatharathorn V, Fay JW, Klein JL, Przepiorka D et al. Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients. Bone Marrow Transplant 1997; 20: 49\u201351.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201064_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","volume":"27","author":"TR Spitzer","year":"2001","unstructured":"Spitzer TR . Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893\u2013898.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201064_CR24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.143.2.718","volume":"143","author":"MJ Tocci","year":"1989","unstructured":"Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989; 143: 718\u2013726.","journal-title":"J Immunol"},{"key":"BFbmt201064_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(93)80167-S","volume":"327","author":"O Fardel","year":"1993","unstructured":"Fardel O, Lecureur V, Guillouzo A . Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes. FEBS Lett 1993; 327: 189\u2013193.","journal-title":"FEBS Lett"},{"key":"BFbmt201064_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0014-5793(98)01663-9","volume":"442","author":"M Demeule","year":"1999","unstructured":"Demeule M, Jodoin J, Beaulieu E, Brossard M, B\u00e9liveau R . Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett 1999; 442: 208\u2013214.","journal-title":"FEBS Lett"},{"key":"BFbmt201064_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0014-2999(03)01481-X","volume":"466","author":"S Krusekopf","year":"2003","unstructured":"Krusekopf S, Roots I, Kleeberg U . Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43. Eur J Pharmacol 2003; 466: 7\u201312.","journal-title":"Eur J Pharmacol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201064","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T18:42:56Z","timestamp":1711392176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["BFbmt201064"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2010.64","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,12]]},"assertion":[{"value":"23 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}